The recent identification of mutations in the gene, MECP2, in girls with Rett syndrome (RS) firmly establishes the molecular genetic basis of this X-linked dominant disorder. This discovery, with ramifications far beyond establishing the gene for RS, represents a dramatic conclusion to an intensive, decade-long search. MECP2 encodes a methyl-CpG-binding protein (MeCP2) involved in transcriptional silencing of a yet to be defined number and type of genes. The clinical spectrum of resultant disorders extends well beyond RS. Indeed, the clinical phenotypes for MECP2 mutations range from mild disability in the mother of a girl with RS to rapidly progressive encephalopathy in her brother. Further, the recent identification of MECP2 mutations in boys with phenotypes quite different from RS adds yet another element to the mix. Within the classic RS group, clinical severity varies remarkably, depending at least in part on the degree of non-random X-inactivation. Those with clinical patterns in the border zones of RS remain to be examined fully for less severe mutational events. Further, the pathobiology of RS and the role of transcriptional silencing as a disease-producing mechanism could be a prototype for other disorders of neurodevelopment. Thus, the identification of mutations in MECP2 creates completely new vistas as to fundamental neurobiologic processes, to disease mechanisms in the neurodevelopmental disabilities, and to potential new therapeutic strategies for RS and related disorders.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Brain and Development
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Über ein eigenartiges hirnatrophisches Syndrom bei Hyperammonamie im Kindesalter [German].Wiener Medizinische Wochenschrift. 1966; 116: 723-726
- A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.Ann Neurol. 1983; 14: 471-479
- MacKeith Press, London1993: 1-120 Rett syndrome – clinical and biological aspects.
- Diagnostic criteria for Rett syndrome. The Rett Syndrome Diagnostic Criteria Work Group.Ann Neurol. 1988; 23: 425-428
- Rett variants: a suggested model for inclusion criteria.Pediatr Neurol. 1994; 11: 5-11
- Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.Nat Genet. 1999; 23: 185-188
- Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes.Ann Neurol. 2000; 47: 670-679
- Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots.Am J Hum Genet. 1999; 65: 1520-1529
- Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location.Hum Mol Genet. 2000; 9: 1119-1129
- Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients.Hum Mol Genet. 2000; 9: 1369-1375
- Mutation screening in Rett syndrome patients.J Med Genet. 2000; 37: 250-255
- Cytogenic and molecular-cytogenic investigation of Rett syndrome: analysis of 31 cases.NeuroReport. 1996; 8: 187-189
- Rett syndrome in a boy with a 47,XXY karyotype [letter; comment].Am J Hum Gene. 1999; 64: 1781-1785
- Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males.Lancet. 2000; 356: 830-832
- Preserved speech variant is allelic of classic Rett syndrome.Eur J Hum Genet. 2000; 8: 325-330
- A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males.Am J Hum Genet. 2000; 67: 982-985
- Neonatal encephalopathy in two boys in families with recurrent Rett syndrome.J Child Neurol. 1998; 13: 229-231
- Selective dendritic alterations in the cortex of Rett syndrome.J Neuropath Exp Neurol. 1995; 54: 195-201
- Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with Trisomy 21.J Neuropath Exp Neurol. 1998; 57: 1013-1017
- The pattern of growth failure in Rett syndrome.Am J Dis Child. 1993; 147: 633-637
☆Presented in part at the World Congress on Rett Syndrome 2000, Karuizawa Nagano Japan, July, 2000.
© 2001 Elsevier Science B.V. Published by Elsevier Inc. All rights reserved.